insights_auto
Why is 3692 up 6.83%?
Dive Deeperchevron_right
3692:HKG
Hansoh Pharmaceutical Group Company Ltd
HK$34.12
arrow_upward
+6.83%(+2.18) 1D
Nov 4, 4:08:09 PM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3692...
Open
HK$32.50
High
HK$34.18
Low
HK$32.16
Mkt. cap
206.91B
Avg. vol.
10.38M
Volume
16.22M
Dividend
1.42%
Quarterly dividend
HK$0.12
Ex-dividend date
Sep 22, 2026
P/E ratio
26.20
52-wk high
HK$44.22
52-wk low
HK$28.06
EPS
HK$1.30
No. of employees
10K
Open
HK$32.50
High
HK$34.18
Low
HK$32.16
Mkt. cap
206.91B
Avg. vol.
10.38M
Volume
16.22M
Dividend
1.42%
Quarterly dividend
HK$0.12
Ex-dividend date
Sep 22, 2026
P/E ratio
26.20
52-wk high
HK$44.22
52-wk low
HK$28.06
EPS
HK$1.30
No. of employees
10K
News stories
From web sources and news partners
Virginia Business
·
1 hour ago
Accendra Health could be delisted by NYSE
Springfield News-Sun
·
6 minutes ago
Stocks surge, and the Dow soars 1,500 points as oil prices tumble following the US midterm elections
Yahoo Finance
·
34 minutes ago
Expedia (NASDAQ:EXPE) posts better-than-expected sales in Q3 2026 but stock drops
Profile
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
About Hansoh Pharmaceutical Group Company Ltd